Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease

American Journal of Cardiology

Volumn 80, Issue 6, 1997, Pages 716-720

  Shehata, Adel R ^b   Ahlberg, Alan W ^b   Gillam, Linda D ^b   Mascitelli, Victor A ^b   Piriz, Jose M ^b   Fleming, Rene A ^b   Chen, Chunguang ^b   Waters, David D ^b   Heller, Gary V ^a  

^a HARTFORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARBUTAMINE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; SCINTIANGIOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOTONIC AGENTS; CATECHOLAMINES; CORONARY DISEASE; CROSS-OVER STUDIES; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031572275     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00501-8     Document Type: Article

References (12)

1. 1. Bailey IK, Griffith LSC, Rouleau J, Strauss HW, Pitt B. Thallium-201 myocardial perfusion imaging at rest and during exercise. Circulation 1976;55:79-87.
2. 2. Ryan T, Feigenbaum H. Exercise echocardiography. Am J Cardiol 1992;69: 82H-89H.
3. 3. Verani MS, Mahmarian JJ. Myocardial perfusion scintigraphy during maximal coronary artery vasodilatation with adenosine. Am J Cardiol 1991;67:12D-17D.
4. 4. Herman SD, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messinger DE, Cloutier DJ, Ahlberg AW, Heller GV. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994;73:164-169.
5. 5. Pennel DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991;18:1471-1479.
6. 6. Bach DS, Armstrong WF. Dobutamine stress echocardiography. Am J Cardiol 1992;69:90H-96H.
7. 7. Young M, Pan W, Wiesner J, Bullough D, Browne G, Balow G, Potter S, Metzner K, Mullane K. Characterization of arbutamine: a novel catecholamine stress agent for diagnosis of coronary disease. Drug Development Res 1994;32: 19-28.
8. 8. Hammond HK, McKirnan MD. Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. J Am Coll Cardiol 1994;23:475-482.
9. 9. Marwick TH. Arbutamine stress testing with closed loop drug delivery, toward the ideal or just another pharmacologic stress technique? J Am Coll Cardiol 1995;26:1176-1179.
10. 10. Woolson RF. Statistical Methods for the Analysis of Biomedical Data. New York: John Wiley, 1987:149-156, 366-369.
11. 11. Tuttle RR, Mills J. Dobutamine: development of a new chatecholamine to selectively increase cardiac contractility. Circ Res 1975;36:185-196.
12. 12. Fioretti PM, Poldermans D, Salustri A, Forster T, Bellotti P, Boersma E, McNeill AJ, El Said ESM, Roelandt JRTC. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 1994;15:355-360.